The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases
Posted on: Monday, 18 May 2009, 07:00 CDT
The Institut Pasteur and Merieux Alliance (which comprises the companies: bioMerieux, Transgene, Shantha Biotechnics, ABL and Silliker) would like to pool their resources and efforts to fight infectious diseases through major research projects, spanning the following fields:
- Clinical diagnostics and theranostics (in partnership with bioMerieux and Transgene) - Food safety and microbiological control, nutrition, health and environment (with bioMerieux and Silliker) - Immunotherapy (with Transgene and Shantha Biotechnics)The research projects under consideration must focus on major pathologies calling upon expertise in the fields of virology, bacteriology and immunology. The results of these joint research projects could be utilized by the Merieux Alliance companies and would enhance the Institut Pasteur's patent portfolio, contributing to the valorization of its research efforts.
This collaboration between a world-renowned scientific foundation and a major bioindustrial group exemplifies the cross-disciplinary approach needed to develop new solutions for fighting infectious diseases. It also represents a new and significant milestone in the collaboration between the Institut Pasteur and a group sharing Pasteurian roots, dedicated to biology and serving public health worldwide.
The signature of this letter of intent follows an agreement signed
between the Institut Pasteur and the Fondation Merieux on
"I am extremely pleased with this agreement with Merieux Alliance that will contribute to improving public health worldwide," stated Alice Dautry, president of the Institut Pasteur. "Together, we want to develop innovative approaches that will allow us, in the future, to win new battles against disease."
"I am happy to reinforce our innovation capabilities for major public health issues through this agreement," declared Alain Merieux, president of Merieux Alliance. "Reconnecting with a long, Pasteurian family legacy, I am certain that our work together will open new horizons for tomorrow's medicine."
About Institut Pasteur
The Institut Pasteur is one of the world's leading biomedical research
centre. Founded by Louis Pasteur in 1887, it is a private, non-profit
foundation dedicated to the prevention and treatment of diseases through
biological research, education and public-health activities. Close to 2,600
people work on its campus in
About Merieux Alliance
Drawing on a long tradition and renowned expertise in bioindustry, Merieux Alliance, the family holding company of Alain Merieux, is dedicated to constantly improving patient care worldwide by developing new biotechnology-based solutions.
Merieux Alliance comprises five companies dedicated to public health that span the full range of healthcare: prevention, diagnosis, prognosis, treatment and clinical follow-up:
- bioMerieux, based in Marcy l'Etoile (France), which is 59%-controlled. A worldwide group specialized in the field of in vitro diagnostics and industrial microbiological testing; - Silliker, based in Chicago (US), which is 89%-controlled. A network of food testing and consulting laboratories; - Shantha Biotechnics Ltd, based in Hyderabad (India), which is 80%-controlled. Specialized in developing and producing vaccines and therapeutic proteins; - Transgene, based in Strasbourg (France), which is 55%-controlled. Dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases; - ABL Inc (Advanced BioScience Laboratories), based in Washington D.C. (US), which is 100%-owned. Specialized in virological research. Under the leadership of Alain Merieux, 10,000 people worldwide are part
of Merieux Alliance. The group achieved consolidated revenues of
http://www.merieux-alliance.com
SOURCE The Institut Pasteur and Merieux Alliance
Source: PR Newswire
Related Articles
- Alameda Alliance for Health Selected to Participate in New National Pediatric Asthma Intervention Initiative
- VistaGen Signs Research Alliance With UHN and McEwen Centre
- Synova Joins Solar Cell Research Alliance
- Chevron Forms Research Alliance With Penn State University to Develop Next Generation of Coal Conversion Technologies
- Medistem Commences Pre-Clinical Research With Lawson Health Research Institute in London, Ontario in the Treatment of Autoimmune Diseases
- National Institutes of Health and National Institute of Allergy and Infectious Disease Programs Protected By Franek Technologies
- Foundation for Clinical Research in Inflammatory Bowel Disease Launches MyIBD.Org
- Friedreich's Ataxia Research Alliance (FARA) Awards Edison Pharmaceuticals $3 Million Development Grant
- US Researchers Cure Inherited Liver Disease in Rats With Genetherapy
 |
 |
User Comments (0)
RSS Feeds